{"log_id": 2607031777611320947, "direction": 0, "words_result_num": 25, "words_result": [{"probability": {"variance": 1e-05, "average": 0.998125, "min": 0.987541}, "location": {"width": 802, "top": 220, "height": 52, "left": 219}, "words": "当接受阿昔替尼治疗时,应建议育龄妇女避孕。如果在妊娠期间使用本品,或者如"}, {"probability": {"variance": 2.5e-05, "average": 0.997439, "min": 0.969587}, "location": {"width": 846, "top": 276, "height": 53, "left": 175}, "words": "果接受本品的患者怀孕,应告知患者药物对胎儿的潜在危害(见【孕妇及哺乳期妇女用"}, {"probability": {"variance": 0.000409, "average": 0.984816, "min": 0.956212}, "location": {"width": 55, "top": 356, "height": 26, "left": 176}, "words": "药】)"}, {"probability": {"variance": 0, "average": 0.998316, "min": 0.99814}, "location": {"width": 47, "top": 411, "height": 25, "left": 176}, "words": "乳糖"}, {"probability": {"variance": 1.7e-05, "average": 0.997701, "min": 0.982282}, "location": {"width": 798, "top": 437, "height": 56, "left": 221}, "words": "本品含有乳糖。患有罕见遗传疾病包括半乳糖不耐受、Lapp乳糖酶缺乏或葡萄糖"}, {"probability": {"variance": 9.8e-05, "average": 0.996409, "min": 0.958669}, "location": {"width": 362, "top": 508, "height": 39, "left": 178}, "words": "半乳糖吸收不良的患者不应服用本品"}, {"probability": {"variance": 5.6e-05, "average": 0.996015, "min": 0.971388}, "location": {"width": 297, "top": 566, "height": 35, "left": 179}, "words": "对驾驶和使用机器能力的影响"}, {"probability": {"variance": 5.9e-05, "average": 0.998047, "min": 0.953298}, "location": {"width": 806, "top": 602, "height": 53, "left": 223}, "words": "阿昔替尼对驾驶和使用机器能力的影响很小。应将阿昔替尼治疗过程中患者可能发"}, {"probability": {"variance": 3.5e-05, "average": 0.996364, "min": 0.978877}, "location": {"width": 370, "top": 671, "height": 39, "left": 182}, "words": "生的事件例如头晕和或疲劳告知患者"}, {"probability": {"variance": 7e-06, "average": 0.998343, "min": 0.990391}, "location": {"width": 262, "top": 727, "height": 34, "left": 189}, "words": "【孕妇及哺乳期妇女用药】"}, {"probability": {"variance": 0, "average": 0.744293, "min": 0.744293}, "location": {"width": 55, "top": 722, "height": 78, "left": 861}, "words": "公"}, {"probability": {"variance": 3e-06, "average": 0.997733, "min": 0.994875}, "location": {"width": 92, "top": 789, "height": 27, "left": 184}, "words": "孕妇用药"}, {"probability": {"variance": 0.006439, "average": 0.983441, "min": 0.504914}, "location": {"width": 847, "top": 814, "height": 63, "left": 227}, "words": "目前尚无在孕妇中服用阿昔替尼的充分和对照的研究。根据其作用机制,当孕妇服A"}, {"probability": {"variance": 0.012009, "average": 0.96397, "min": 0.544957}, "location": {"width": 890, "top": 848, "height": 87, "left": 184}, "words": "用阿昔替尼时,可能导致对胎儿的伤害。在小鼠发育毒性研究中,当母体暴露量低于份"}, {"probability": {"variance": 1.3e-05, "average": 0.997892, "min": 0.983574}, "location": {"width": 835, "top": 929, "height": 53, "left": 187}, "words": "床推荐剂量的人体暴露量时,观察到阿昔替尼有致畸性、胚胎毒性和胎儿毒性。因此"}, {"probability": {"variance": 7e-06, "average": 0.998552, "min": 0.984591}, "location": {"width": 847, "top": 984, "height": 53, "left": 189}, "words": "当拟接受阿昔替尼治疗时,应建议患者避孕。如果本品在妊娠期间使用,或当患者接受"}, {"probability": {"variance": 3e-06, "average": 0.998703, "min": 0.994178}, "location": {"width": 519, "top": 1048, "height": 43, "left": 190}, "words": "本品治疗时怀孕,应告知患者药物对胎儿的潜在危害"}, {"probability": {"variance": 1e-06, "average": 0.999245, "min": 0.996098}, "location": {"width": 804, "top": 1092, "height": 53, "left": 233}, "words": "在交配前及第一周妊娠期间,将阿昔替尼灌胃给予雌性小鼠,每日给药两次,在所"}, {"probability": {"variance": 0.002118, "average": 0.989224, "min": 0.693459}, "location": {"width": 847, "top": 1147, "height": 56, "left": 191}, "words": "有试验剂量组(≥15mg/kg/剂量,是患者以推荐起始剂量给药所得全身暴露量AUC]的"}, {"probability": {"variance": 0.00274, "average": 0.988998, "min": 0.667357}, "location": {"width": 849, "top": 1202, "height": 56, "left": 191}, "words": "约10倍)中,观察到着床后损失率升高。在胚胎-胎仔毒性研究中,妊娠小鼠在脏器形"}, {"probability": {"variance": 0.00133, "average": 0.988122, "min": 0.772913}, "location": {"width": 845, "top": 1257, "height": 56, "left": 194}, "words": "成期间经灌胃接受剂量为0.15、0.5、1.5mg/kg/剂量的阿昔替尼(每日给药两次)。在"}, {"probability": {"variance": 0.000495, "average": 0.991994, "min": 0.854369}, "location": {"width": 848, "top": 1312, "height": 58, "left": 195}, "words": "15mg/kg/剂量组中(该剂量是以推荐起始剂量给予患者所得AUC的约0.5倍),当无母"}, {"probability": {"variance": 0.006078, "average": 0.978819, "min": 0.547866}, "location": {"width": 848, "top": 1368, "height": 56, "left": 196}, "words": "体毒性时观察到的胚胎胎仔毒性包括畸形(腭裂),在≥0.5mg/kg/剂量组中(以推荐起"}, {"probability": {"variance": 0.00022, "average": 0.993634, "min": 0.921857}, "location": {"width": 807, "top": 1424, "height": 56, "left": 196}, "words": "始剂量给予患者所得AUC的约0.15倍),观察到的胚胎胎仔毒性为骨骼钙化异常"}, {"probability": {"variance": 8e-06, "average": 0.996844, "min": 0.991018}, "location": {"width": 139, "top": 1582, "height": 25, "left": 558}, "words": "第13页,共27页"}], "language": 3}